ACTU | NASDAQ

Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc. (ACTU) | runway 4.2 months | financing risk high | market cap $68.8M. Daily snapshot of financials, capital pressure, and recent d...

Company websiteLast updated Apr 28, 2026

Share price

$2.88

As of Apr 28, 2026

Market cap

$68.8M

Snapshot valuation

30D volume

176,841 shares

Rolling average daily volume

Runway

4.2 months

Estimated from precomputed burn and cash

Financing risk

N/A

The company screens as likely to return to the capital markets soon.

Snapshot summary

Runway: 4.2 months based on estimated burn.

Recent financing detected on Nov 27, 2025.

Financing signal: The company screens as likely to return to the capital markets soon.

Recent developments

ACTUATE THERAPEUTICS, INC. 10-K 2026-03-26

10-K filed on 2026-03-26.

Mar 25, 2026, 8:00 PM

ACTUATE THERAPEUTICS, INC. 8-K 2026-01-12

8-K filed on 2026-01-12.

Jan 11, 2026, 7:00 PM

ACTUATE THERAPEUTICS, INC. 8-K 2025-11-28

8-K filed on 2025-11-28.

Nov 27, 2025, 7:00 PM

ACTUATE THERAPEUTICS, INC. 424B5 2025-11-28

424B5 filing submitted on 2025-11-28.

Nov 27, 2025, 7:00 PM

ACTUATE THERAPEUTICS, INC. 8-K 2025-11-21

8-K filed on 2025-11-21.

Nov 20, 2025, 7:00 PM

Premium analysis

Full filing analysis and proprietary signal detail

Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.

Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures